Chronic obstructive pulmonary disease (COPD) is a serious, yet preventable and treatable, disease. The success of its treatment relies largely on the proper implementation of recommendations, such as the recently released Global Strategy for Diagnosis, Management, and Prevention of COPD (GOLD 2011, of late December 2011). The primary objective of this study was to examine the extent to which GOLD 2011 is being used correctly among Czech respiratory specialists, in particular with regard to the correct classification of patients. The secondary objective was to explore what effect an erroneous classification has on inadequate use of inhaled corticosteroids (ICS). In order to achieve these goals, a multi-center, cross-sectional study was conducted, consisting of a general questionnaire and patient-specific forms. A subjective classification into the GOLD 2011 categories was examined, and then compared with the objectively computed one. Based on 1,355 patient forms, a discrepancy between the subjective and objective classifications was found in 32.8% of cases. The most common reason for incorrect classification was an error in the assessment of symptoms, which resulted in underestimation in 23.9% of cases, and overestimation in 8.9% of the patients' records examined. The specialists seeing more than 120 patients per month were most likely to misclassify their condition, and were found to have done so in 36.7% of all patients seen. While examining the subjectively driven ICS prescription, it was found that 19.5% of patients received ICS not according to guideline recommendations, while in 12.2% of cases the ICS were omitted, contrary to guideline recommendations. Furthermore, with consideration to the objectively-computed classification, it was discovered that 15.4% of patients received ICS unnecessarily, whereas in 15.8% of cases, ICS were erroneously omitted. It was therefore concluded that Czech specialists tend either to under-prescribe or overuse inhaled corticosteroids.

CEEOR Institute Prague Czech Republic

Chest Clinic Ostrava Poruba Czech Republic

Department of Respiratory Medicine and Tuberculosis Faculty of Medicine and Dentistry Palacky University Olomouc and University Hospital Olomouc Ostrava Poruba Czech Republic

Department of Respiratory Medicine and Tuberculosis Faculty of Medicine Masaryk University Brno and University Hospital Brno Brno Czech Republic

Pulmonary Department Faculty of Medicine in Hradec Kralove Charles University Prague and University Hospital Hradec Kralove Hradec Kralove Czech Republic

Zobrazit více v PubMed

Caballero A, Torres-Duque CA, Jaramillo C, Bolívar F, Sanabria F, et al. (2008) Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). Chest 133(2): 343–349. PubMed

Buist SA, Vollmer WM (2008) McBurnie (2008) Worldwide burden of COPD in high- and low- income countries. Part I. The burden of obstructive lung disease (BOLD). Int J Tuberc Lung Dis 12(7): 703–708. PubMed

Bridevaux PO, Probst-Hensch NM, Schindler C, Curjuric I, Felber Dietrich D, et al. (2010) Prevalence of airflow obstruction in smokers and never-smokers in Switzerland. Eur Respir J 36(6): 1259–1269. PubMed

Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3: e442. PubMed PMC

World Health Organization. Burden of COPD. Available: http://www.who.int/respiratory/copd/burden/en/. Accessed 5 June 2013.

World Health Organization WHO Europe detailed mortality datafiles. Available: http://www.euro.who.int/en/what-we-do/data-and-evidence/databases/european-detailed-mortality-database-dmdb2. Accessed 1 April 2012.

Poznańska A, Wojtyniak B, Seroka W (2011) Main causes of death among Polish population in 2030. Przegl Epidemiol 65(3): 483–489. PubMed

Maly M, Zvolsky M, Rozborilova E, Vondra V (2013) Respiratory Mortality in Czech and Slovak Republics in the year 2011. Stud pneumol et phtiseol 73(4): 128–132.

Decramer M, Brusselle G, Buffels J, Corhay JL, De Backer W, et al. (2013) COPD awareness survey: do Belgian pulmonary physicians comply with the GOLD guidelines 2010? Acta Clin Belg 68(5): 325–340. PubMed

Bellamy D, Bouchard J, Henrichsen S, Johansson G, Langhammer A, et al. (2006) International Primary Care Respiratory Group (IPCRG) Guidelines: management of chronic obstructive pulmonary disease (COPD). Prim Care Respir J 15(1): 48–57. PubMed PMC

Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, et al. (2011) Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update for the ACP, ACCP, ATS and ERS. Ann Intern Med 155(3): 179–191. PubMed

Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Updated 2013.Available: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdf Accessed 3 March 2013.

O'Donnell DE, Aaron S, Bourbeau J, Hernandez P, Marciniuk DD, et al. (2007) Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can Respir J 14 Suppl B 5B–32B. PubMed PMC

National Institute for Health and Care Excellence. Chronic obstructive pulmonary disease (updated) Clinical guidelines CG101. Available: http://www.nice.org.uk/CG101 Accessed: 2 April 2013.

Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, et al. (2014) Spanish Guideline for COPD (GesEPOC). Arch Bronchoconeumol 50 Suppl 1 1–16. PubMed

Gupta D, Agarwal R, Aggarwal AN, Maturu VN, Dhooria S, et al. (2013) Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations. Lung India 30(3): 228–67. PubMed PMC

Koblizek V, Chlumsky J, Zindr V, Neumannova K, Zatloukal J, et al. (2013) Chronic Obstructive Pulmonary Disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 157(2): 189–201. PubMed

Glaab T, Vogelmeier C, Hellmann A, Buhl R (2012) Guideline-based survey of outpatient COPD management by pulmonary specialist in Germany. Int J Chron Obstruct Pulmon Dis 7: 101–8. PubMed PMC

Glaab T, Banik N, Rutschmann OT, Wencler M (2006) National survey of guideline-compliant COPD management among pneumologist and primary care physicians. Int J Chron Obstruct Pulmon Dis 3(3): 141–148. PubMed

Desalu OO, Onyedum CC, Adeoti AO, Gundiri LB, Fadare JO, et al. (2013) Guideline-based COPD management in a resource-limited setting - physicians' understanding, adherence and barriers: a cross-sectional survey of internal and family medicine hospital-based physicians in Nigeria. Prim Care Respir J 22(1): 79–85. PubMed PMC

Montanari U, Quadrelli D, Donato G, Mercuri M, Scorletti A, et al. (2013) Implementation of diagnostic accuracy for COPD (ABC Project): evaluation of a guide-line in territorial clinical practice. Recenti Prog Med 104(1): 23–7. PubMed

Sarc I, Jeric T, Ziherl K, Suskovic S, Kosnik M, et al. (2011) Adherence to treatment quidelines and long-term survival in hospitalized patients with chronic obstructive pulmonary disease. J Eval Clin Pract 17(4): 737–43. PubMed

Miravitlles M, Brosa M, Velasco M, Crespo C, Gobartt E, et al. (2009) An economic analysis of pharmacological treatment of COPD in Spain. Resp Med 103(5): 714–721. PubMed

Vestbo J, Vogelmeier C, Small M, Higgins V (2014) Understanding the GOLD 2011 Strategy as applied to a real-world COPD population. Respir Med 108(5): 729–36. PubMed

Kew KM, Dias S, Cates CJ (2014) Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis. Cochrane Database Syst Rev 3: CD010844. PubMed PMC

Kew KM, Senjukovich A (2014) Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 3: CD010115. PubMed PMC

Hoonhorst SJ, ten Hacken NH, Vonk JM, Timens W, Hiemstra PS, et al. (2014) Steroid resistance in COPD? Overlap and differential anti-inflammatory effects in smokers and ex-smokers. PloS One 9(2): e87443. PubMed PMC

Dong YH, Chang CH, Wu FL, Shen LJ, Calverley PM, et al. (2014) Use of inhaled corticosteroids in patients with chronic obstructive pulmonary disease and the risk of tuberculosis and influenza: A systematic review and meta-analysis of randomized controlled trials. Chest Feb 6 [Epub ahead of print]. PubMed

Lee H, Kim J, Tagmazyan K (2013) Treatment of stable chronic obstructive pulmonary disease: the GOLD guidelines. Am Fam Physician 88(10): 655–663. PubMed

Schünenmann HJ, Woodhead M, Anzueto A, Buist AS, Macnee W, et al. (2012) A guide to guidelines for professional societies and other developers of recommendations. Introduction to integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thorac Soc 9(5): 215–218. PubMed

Yawn BP, Akl EA, Qaseem A, Black P, Campos-Outcalt D, et al. (2012) Identifying targed audiences: who are the guidelines for? Article 1 in integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thor Soc 9(5): 219–224. PubMed

Wilt TJ, Guyatt G, Kunz R, Macnee W, Puhan MA, et al. (2012) Deciding what type of evidence and outcomes to include in guidelines. Article 5 in integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thor Soc 9(5): 243–250. PubMed

Grimshaw JM, Schünenmann HJ, Burgers JS, Cruz AA, Heffner J, et al. (2012) Disseminating and implementing guidelines. Article 13 in integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thor Soc 9(5): 298–303. PubMed

Burgers JS, Anzueto A, Black PN, Cruz AA, Fervers B, et al. (2012) Adaptation, evaluation and updating of guidelines. Article 14 in integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thorac Soc 9(5): 304–310. PubMed

Parker DR, Eaton CB, Ahern DK, Roberts MB, Rafferty C, et al. (2013) The study design and rationale of the randomized controlled trial: translating COPD guidelines into primary care practice. BMC Fam Pract 6 14: 56. PubMed PMC

Institute of Health Information and Statistics of the Czech Republic - UZIS. Available: https://uzis.cz/en/category/tematicke-rady/health-statistics/pneumology-phthisiology Accessed 1 April 2014.

Maio S, Baldacci S, Martini F, Cerrai S, Sarno G, et al. (2014) COPD management according to old and new GOLD guidelines: an observational study with Italian general practitioners. Curr Med Res Opin Feb 3 [Epub ahead of print]. PubMed

White P, Thorton H, Pinnock H, Georgopoulou S, Booth HP (2013) Overtreatment of COPD with inhaled corticosteroids – implications for safety and costs: cross-sectional observational study. PLoS One 23 8(10): e75221. PubMed PMC

Lucas AE, Smeenk FW, Smeele IJ, van Schayck CP (2008) Overtreatment with inhaled corticosteroids and diagnostic problems in primary care patients, an exploratory study. Fam Pract 25(2): 86–91. PubMed

Roche N, Pribil C, van Ganse E, Serrier P, Housset B, et al. (2014) Real-life use of fluticasone propionate/salmeterol in patients with chronic obstructive pulmonary disease: a French observational study. BMC Pulm Med 14(1): 56. PubMed PMC

Ford ES, Mannino DM, Giles WH, Wheaton AG, Liu Y, et al. (2014) Prescription practices for Chronic Obstructive Pulmonary Disease: Findings from the National Ambulatory Medical Care Survey 1999–2010. COPD Feb 25 [Epub ahead of print]. PubMed PMC

Smidth M, Christensen MB, Fenger-Grøn M, Olesen F, Vedsted P (2013) The effect of an active implementation of a disease management programme for chronic obstructive pulmonary disease on healthcare utilization—a cluster-randomised controlled trial. BMC Health Serv Res 13: 385. PubMed PMC

Valipour A, Koblizek V, Tkacova R, Tudoric N, Zykov K, et al. (2014) Phenotypes of COPD in Central and Eastern Europe (POPE). Available: https://clinicaltrials.gov/ct2/show/NCT02119494?term=COPD+Czech+republic&rank=2Accessed 8 May 2014.

Breathing Out Completely Before Inhalation: The Most Problematic Step in Application Technique in Patients With Non-Mild Chronic Obstructive Pulmonary Disease

Diagnosing COPD: advances in training and practice - a systematic review

A review of national guidelines for management of COPD in Europe